TriCities.com
Email Facebook Twitter Mobile
|
 
NewsNews

FDA Reviewing Benefits Of Blood Thinner Plavix

FDA Reviewing Benefits Of Blood Thinner Plavix

Federal health officials are investigating whether the blockbuster blood thinner Plavix is less effective in some patients.


»  Comments | Post a Comment

WASHINGTON (AP) - Federal health officials are investigating whether the blockbuster blood thinner Plavix is less effective in some patients.
The Food and Drug Administration is studying reports that taking certain heartburn medications alongside Plavix decreases the benefits of the drug. The FDA is also investigating whether patients' genetic background can interfere with effectiveness.
Plavix is the second-best-selling drug in the world. It is marketed by Bristol-Myers Squibb Co. and Sanofi-Aventis SA.
The companies have agreed to study the effects of genetic factors or heartburn drugs. The studies will take several months to complete.
Until more information is available, the FDA says patients should continue taking Plavix.

(Copyright 2009 by The Associated Press. All Rights Reserved.)

Terms and Conditions

Advertisement

 
 

Advertisement

Reader Comments

*Facebook Account Required to Comment. If you are not already logged into Facebook, please click the comment button to do so.

Deal of the Day

Advertisement

 

Things to Do

Advertisement

Advertisement

Media General
DealTaker.com - Coupons and Deals
DealTaker.com Promo Codes
KewlBoxBoxerJam: Games & Puzzles
Games, Puzzles & Trivia
Blockdot: Advergaming and Branded Media
Advergaming and Branded Media